These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 30627953

  • 1. Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease.
    McCullough PA.
    Cardiol Ther; 2019 Jun; 8(1):145-150. PubMed ID: 30627953
    [Abstract] [Full Text] [Related]

  • 2. Management of Neurogenic Orthostatic Hypotension in Neurodegenerative Disorders: A Collaboration Between Cardiology and Neurology.
    Amjad FS, Beinart SC.
    Neurol Ther; 2021 Dec; 10(2):427-434. PubMed ID: 34494209
    [Abstract] [Full Text] [Related]

  • 3. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
    Mobarek SK.
    BMC Cardiovasc Disord; 2020 Feb 04; 20(1):54. PubMed ID: 32019498
    [Abstract] [Full Text] [Related]

  • 4. Dysautonomia: A Forgotten Condition - Part 1.
    Rocha EA, Mehta N, Távora-Mehta MZP, Roncari CF, Cidrão AAL, Elias Neto J.
    Arq Bras Cardiol; 2021 Apr 04; 116(4):814-835. PubMed ID: 33886735
    [Abstract] [Full Text] [Related]

  • 5. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L, Espay AJ, Gelblum J, Payne R, Dietrich E.
    Postgrad Med; 2015 Apr 04; 127(7):702-15. PubMed ID: 26012731
    [Abstract] [Full Text] [Related]

  • 6. Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review.
    Biswas D, Karabin B, Turner D.
    Int J Gen Med; 2019 Apr 04; 12():173-184. PubMed ID: 31118743
    [Abstract] [Full Text] [Related]

  • 7. Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review.
    Hoxhaj P, Shah S, Muyolema Arce VE, Khan W, Sadeghzadegan A, Singh S, Collado GF, Goyal A, Khawaja I, Botlaguduru D, Razzaq W, Abdin ZU, Gupta I.
    Cureus; 2023 May 04; 15(5):e38907. PubMed ID: 37303338
    [Abstract] [Full Text] [Related]

  • 8. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
    Isaacson SH, Skettini J.
    Vasc Health Risk Manag; 2014 May 04; 10():169-76. PubMed ID: 24729712
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303).
    Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ.
    J Parkinsons Dis; 2016 Oct 19; 6(4):751-759. PubMed ID: 27636856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.
    Pérez-Lloret S, Quarracino C, Otero-Losada M, Rascol O.
    Expert Opin Pharmacother; 2019 Apr 19; 20(6):635-645. PubMed ID: 30730771
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension.
    Olshansky B, Muldowney J.
    Am J Cardiol; 2020 May 15; 125(10):1582-1593. PubMed ID: 32204870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).
    Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G.
    Mov Disord; 2015 Apr 15; 30(5):646-54. PubMed ID: 25487613
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
    François C, Hauser RA, Aballéa S, Dorey J, Kharitonova E, Hewitt LA.
    J Med Econ; 2016 Apr 15; 19(5):515-25. PubMed ID: 26710315
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.
    Elgebaly A, Abdelazeim B, Mattar O, Gadelkarim M, Salah R, Negida A.
    Clin Auton Res; 2016 Jun 15; 26(3):171-80. PubMed ID: 26951135
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.